(Q33502380)

27 July 2017

title

Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset (English)

1 reference

27 July 2017

1 reference

1 reference

Nakamura N

1

1 reference

27 July 2017

Ban T

2

1 reference

27 July 2017

Yamaji K

3

1 reference

27 July 2017

Yoneda Y

4

1 reference

27 July 2017

Wada Y

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Journal of Clinical Investigation

27 July 2017

published in

1 reference

27 July 2017

volume

101

1 reference

27 July 2017

issue

9

1 reference

27 July 2017

page(s)

1951-1959

1 reference

Presence and comparison of Ca2+ transport activity of annexins I, II, V, and VI in large unilamellar vesicles

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Immunology of the antiphospholipid antibody syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

The lupus anticoagulant and eicosanoids

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Heterogeneity and diversity of IgM and IgG lupus anticoagulants in an individual with systemic lupus erythematosus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Antiphospholipid-protein antibodies: laboratory detection and clinical relevance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Binding and Phagocytosis of Apoptotic Vascular Smooth Muscle Cells Is Mediated in Part by Exposure of Phosphatidylserine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

"Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Anti-phospholipid antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Human placental anticoagulant protein: isolation and characterization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Antiphospholipid antibody syndrome: immunologic and clinical aspects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Immunology and Clinical Importance of Antiphospholipid Antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Regulatory effect of antiphospholipid antibodies on signal transduction: a possible model for autoantibody-induced reproductive failure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

The annexins and exocytosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Inhibition of protein kinase C by annexin V

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Antiphospholipid Antibodies: Proposed Mechanisms of Action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=508782

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

31 October 2018

1 reference

12 December 2020

Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation

1 reference

12 December 2020

Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms

1 reference

12 December 2020

Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions

1 reference

12 December 2020

Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties

1 reference

12 December 2020

Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates

1 reference

12 December 2020

Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model

1 reference

12 December 2020

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

1 reference

12 December 2020

beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles

1 reference

12 December 2020

Inhibitors of platelet aggregation and blood coagulation isolated from the human placenta

1 reference

12 December 2020

Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin

1 reference

12 December 2020

Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis

1 reference

12 December 2020

Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays.

1 reference

12 December 2020

Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay

1 reference

12 December 2020

Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2

1 reference

12 December 2020

Apoptotic vascular endothelial cells become procoagulant

1 reference

12 December 2020

Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition

1 reference

12 December 2020

Absence of cell-surface annexin V is accompanied by defective collagen matrix binding in the Swarm rat chondrosarcoma

1 reference

12 December 2020

Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord

1 reference

12 December 2020

Obstetric complications associated with the lupus anticoagulant

1 reference

12 December 2020

Lupus anticoagulant, thrombosis, and fetal loss

1 reference

12 December 2020

An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis

1 reference

12 December 2020

Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation

1 reference

12 December 2020

Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family

1 reference

12 December 2020

Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies

1 reference

12 December 2020

Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V

1 reference

12 December 2020

"Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding

1 reference

12 December 2020

Annexin V perturbs or stabilises phospholipid membranes in a calcium-dependent manner

1 reference

12 December 2020

Answers to the antiphospholipid-antibody syndrome?

1 reference

12 December 2020

The complexity of the phospholipid binding protein Annexin V

1 reference

12 December 2020

Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene

1 reference

12 December 2020

Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulant

1 reference

12 December 2020

Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant

1 reference

12 December 2020

Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis

1 reference

12 December 2020

Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin

1 reference

12 December 2020

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

12 December 2020

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

1 reference

12 December 2020

Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome

1 reference

12 December 2020

Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI119889

1 reference

27 July 2017

1 reference

27 July 2017

1 reference